Synthesis and Characterization of Telmisartan‐Derived Cell Death Modulators to Circumvent Imatinib Resistance in Chronic Myeloid Leukemia

New strategies to eradicate cancer stem cells in chronic myeloid leukemia (CML) include a combination of imatinib with peroxisome proliferator‐activated receptor gamma (PPARγ) ligands. Recently, we identified the partial PPARγ agonist telmisartan as effective sensitizer of resistant K562 CML cells t...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoepf, Anna M., Salcher, Stefan, Hohn, Verena, Veider, Florina, Obexer, Petra, Gust, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318623/
https://www.ncbi.nlm.nih.gov/pubmed/32298535
http://dx.doi.org/10.1002/cmdc.202000092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318623/
https://www.ncbi.nlm.nih.gov/pubmed/32298535
http://dx.doi.org/10.1002/cmdc.202000092

Ejemplares similares